1.Centers for Disease Control and Prevention (CDC). Global disease elimination and eradication as public health strategies. Proceedings of a conference. Atlanta, Georgia, USA. 23-25 February 1998. MMWR Morb Mortal Wkly Rep 1999;48(suppl):1-208. http://www.cdc.gov/mmwr/pdf/other/mm48su01.pdf. Accessed 26 August 2010.
2.Dowdle WR. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1989;38(suppl S-3):1–25.
3.Centers for Disease Control and Prevention. The national plan to eliminate syphilis from the United States. Atlanta, GA: US Department of Health and Human Services; 2006.
4.Notes from the decennial [commentary]. Am J Infect Control 2010;38(5):337–340.
5.Klevens R, Edwards JR, Richards CL, et al.Estimating healthcare-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007;122:160–166.
6.World Health Organization. WHO guidelines on hand hygiene in health care. The first global patient safety challenge: clean care is safer care. Geneva: World Health Organization; 2009.
7.Hidron AI, Edwards JR, Patel J, et al.NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996–1011.
8.Perman JW. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci-from disaster to ongoing control. J Hosp Infect 2006;63(1):14–26.
9.Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and meth-icillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009;64(suppl 1):i11–i17.
10.Carlet J, Astagneau P, Brun-Buisson C, et al.French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009;30:737–745.
11.Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009;301(7):727–736.
13. American Recovery and Reinvestment Act of 2009, Pub L No. 111-115, 111 Stat 1 (2009).
14.McKibben L, Horan T, Tokars JI, et al.Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control 2005;33:217–226.
15. Deficit Reduction Act, Pub L No. 109-171, 109 Stat 1932 (2006).
16. Patient Protection and Affordable Care Act, Pub L No. 111-148, 111 Stat 3590 (2010).
17. Hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates, 75 Federal Register 157 (2010) (codified at 42 CFR §411-§422 and §489).
18.Pronovost P, Needham D, Berenholtz S, et al.An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl ] Med 2006;355:2725–2732.
19.Centers for Disease Control and Prevention (CDC). Reduction in central line-associated bloodstream infections among patients in intensive care units–Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005;54:1013–1016.
20.Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control 2008;36:S171.el–S171.e5.
21. 5 Million Lives Campaign. Getting started kit: prevent central line infections how-to guide. Cambridge, MA: Institute for Healthcare Improvement; 2008. http://www.ihi.org. Accessed 6 July 2010.
23.Yokoe DS, Mermel LA, Anderson DJ, et al.A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S12–S21.
25.Pronovost P. Overview of STOP-BSI program. Oral presentation to Healthcare Infection Control Practices Advisory Committee (HICPAC); November 2009; Washington, DC.
26.Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665–674.
27.The Research Committee of the Society of Healthcare Epidemiology of America. Enhancing patient safety by reducing healthcare-associated infections: the role of discovery and dissemination. Infect Control Hosp Epidemiol 2010;31:118–123.